InoRx is a next-generation Contract Research Organization (CRO) accelerating clinical development through innovation, patient access, and operational excellence. Backed by the SRM Group, a $1.4 billion global enterprise with deep roots in healthcare and research, InoRx delivers faster, more reliable, and cost-effective clinical studies for biotech sponsors worldwide.
With an integrated site network, advanced technology, and a patient-centric approach, InoRx helps sponsors design smarter trials, activate sites quickly, and achieve earlier proof-of-concept milestones—without sacrificing quality or transparency.
Direct affiliation with SRM’s extensive hospital network provides access to large and diverse patient populations across multiple therapeutic areas. This enables faster recruitment, earlier proof-of-concept, and timely execution—critical milestones for emerging biotech programs.
Direct affiliation with SRM’s extensive hospital network provides access to large and diverse patient populations across multiple therapeutic areas. This enables faster recruitment, earlier proof-of-concept, and timely execution—critical milestones for emerging biotech programs.
With SRM’s decades-long reputation in healthcare, education, and research, InoRx delivers credibility, stability, and experienced clinical oversight—ensuring trials meet global standards with uncompromising quality.
Combine real-world data, physician insights, and predictive modeling to identify patients with precision and accelerate recruitment
Streamlined regulatory and contractual workflows to launch trials in weeks, not months
Expert protocol development and study reporting with scientific precision
End-to-end project management ensuring compliance, patient safety, faster patient enrollment, and on-time delivery
Deliver clean, compliant data and rapid, reliable analyses that accelerate decisions and drive regulatory success
SRM hospitals, 150+ rigorously vetted sites, 800+ Primary Investigators, and large patient populations across diverse therapeutic areas to accelerate enrollment
We help plan smarter clinical trials by focusing on patients, feasibility, and enrollment strategies that reduce risk and keep studies on track.
SRM’s molecular diagnostic center includes a Biosafety Level 3 facility with NABL accreditation performing advanced viral PCR, and has participated as a site in major vaccine trials including COVAXIN.
SRM’s clinical and diagnostic services include pulmonary function testing, bronchoscopy, automated TB and infectious respiratory disease diagnostics—supporting studies in COPD, asthma, TB, and post-COVID conditions.
